Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon P Kim

Showing results (111-120 of 211) with videos related to

Pageof 22
Sort By:
BJU International|September 24, 2013
Population-based analysis of prostate-specific antigen (PSA) screening in younger men (<55 years) in AustraliaWeranja K B Ranasinghe, Simon P Kim, Nathan Lawrentschuk, et al.
European Urology Oncology|August 15, 2019
A Cost-effectiveness Analysis of Systemic Therapy for Metastatic Hormone-sensitive Prostate CancerNiranjan J Sathianathen, Fernando Alarid-Escudero, Karen M Kuntz, et al.
The Journal of Urology|February 4, 2017
Redefining and Contextualizing the Hospital Volume-Outcome Relationship for Robot-Assisted Radical Prostatectomy: Implications for Centralization of CareBoris Gershman, Sarah K Meier, Molly M Jeffery, et al.
The Yale Journal of Biology and Medicine|June 2, 2015
The cost of cancer-related physician services to MedicareSean Maroongroge, Simon P Kim, Sarah Mougalian, et al.
Urology Practice|November 1, 2023
Association of Frailty and Complications Following Prostate Biopsy: Results From a Population-Based, Privately Insured CohortKayvon Kiani, Simon P Kim, Rodrigo Rodrigues Pessoa, et al.
Urology|September 10, 2011
Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinomaSimon P Kim, Christopher J Weight, Bradley C Leibovich, et al.
BJU International|January 23, 2014
Variation in performance of candidate surgical quality measures for muscle-invasive bladder cancer by hospital typeAnthony T Corcoran, Elizabeth Handorf, Daniel Canter, et al.
Cancer|September 7, 2012
Assessment of the pathologic inclusion criteria from contemporary adjuvant clinical trials for predicting disease progression after nephrectomy for renal cell carcinomaSimon P Kim, Paul L Crispen, R Houston Thompson, et al.
Urologic Oncology|January 21, 2022
Radical cystectomy versus trimodality therapy for muscle-invasive urothelial carcinoma of the bladderKenneth Softness, Sumedh Kaul, Aaron Fleishman, et al.
Urologic Oncology|December 5, 2022
Urothelial carcinoma of the bladder with isolated lymph node metastasis: Natural history and outcomes following surgical resectionErnest Morton, Sumedh Kaul, Aaron Fleishman, et al.
Pageof 22

Showing results (111-120 of 211) with videos related to

Sort By:
Pageof 22
BJU International|September 24, 2013
Population-based analysis of prostate-specific antigen (PSA) screening in younger men (<55 years) in AustraliaWeranja K B Ranasinghe, Simon P Kim, Nathan Lawrentschuk, et al.
European Urology Oncology|August 15, 2019
A Cost-effectiveness Analysis of Systemic Therapy for Metastatic Hormone-sensitive Prostate CancerNiranjan J Sathianathen, Fernando Alarid-Escudero, Karen M Kuntz, et al.
The Journal of Urology|February 4, 2017
Redefining and Contextualizing the Hospital Volume-Outcome Relationship for Robot-Assisted Radical Prostatectomy: Implications for Centralization of CareBoris Gershman, Sarah K Meier, Molly M Jeffery, et al.
The Yale Journal of Biology and Medicine|June 2, 2015
The cost of cancer-related physician services to MedicareSean Maroongroge, Simon P Kim, Sarah Mougalian, et al.
Urology Practice|November 1, 2023
Association of Frailty and Complications Following Prostate Biopsy: Results From a Population-Based, Privately Insured CohortKayvon Kiani, Simon P Kim, Rodrigo Rodrigues Pessoa, et al.
Urology|September 10, 2011
Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinomaSimon P Kim, Christopher J Weight, Bradley C Leibovich, et al.
BJU International|January 23, 2014
Variation in performance of candidate surgical quality measures for muscle-invasive bladder cancer by hospital typeAnthony T Corcoran, Elizabeth Handorf, Daniel Canter, et al.
Cancer|September 7, 2012
Assessment of the pathologic inclusion criteria from contemporary adjuvant clinical trials for predicting disease progression after nephrectomy for renal cell carcinomaSimon P Kim, Paul L Crispen, R Houston Thompson, et al.
Urologic Oncology|January 21, 2022
Radical cystectomy versus trimodality therapy for muscle-invasive urothelial carcinoma of the bladderKenneth Softness, Sumedh Kaul, Aaron Fleishman, et al.
Urologic Oncology|December 5, 2022
Urothelial carcinoma of the bladder with isolated lymph node metastasis: Natural history and outcomes following surgical resectionErnest Morton, Sumedh Kaul, Aaron Fleishman, et al.
Pageof 22